Lee, J.; Chang, B.-S.; Kim, H.; Kim, S.T.; Jang, S.; Chang, S.Y.
Role of Denosumab in Patients with Intermediate Spinal Instability Neoplastic Score (SINS). Cancers 2025, 17, 1539.
https://doi.org/10.3390/cancers17091539
AMA Style
Lee J, Chang B-S, Kim H, Kim ST, Jang S, Chang SY.
Role of Denosumab in Patients with Intermediate Spinal Instability Neoplastic Score (SINS). Cancers. 2025; 17(9):1539.
https://doi.org/10.3390/cancers17091539
Chicago/Turabian Style
Lee, JunYeop, Bong-Soon Chang, Hyoungmin Kim, Sung Taeck Kim, Seonpyo Jang, and Sam Yeol Chang.
2025. "Role of Denosumab in Patients with Intermediate Spinal Instability Neoplastic Score (SINS)" Cancers 17, no. 9: 1539.
https://doi.org/10.3390/cancers17091539
APA Style
Lee, J., Chang, B.-S., Kim, H., Kim, S. T., Jang, S., & Chang, S. Y.
(2025). Role of Denosumab in Patients with Intermediate Spinal Instability Neoplastic Score (SINS). Cancers, 17(9), 1539.
https://doi.org/10.3390/cancers17091539